Decera Clinical Education Infectious Disease Podcast

In this episode, Daniel R. Kuritzkes, MD, and Michelle S. Cespedes, MD, MS, discuss new ART data from virtual CROI 2021.Michelle S. Cespedes, MD, MSAssociate Professor of MedicineDivision of Infectious DiseaseDepartment of MedicineIcahn School of Medicine at Mount SinaiAttending PhysicianMount Sinai Medical CenterNew York, New YorkDaniel R. Kuritzkes, MD Chief, Division of Infectious DiseasesBrigham and Women’s HospitalProfessor of MedicineHarvard Medical SchoolBoston, MassachusettsContent based on a CME program supported by an independent educational grant from ViiV Healthcare.Link to full program:https://bit.ly/3ux6FF8 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Ethel D. Weld, MD, PhD, demonstrates the use of HIV-ASSIST, a free, online, decision support tool to inform ART selection.Ethel D. Weld, MD, PhDAssistant Professor of Medicine, Pharmacology, & Molecular SciencesDivision of Clinical PharmacologyDepartment of Infectious DiseasesJohns Hopkins University School of MedicineAttending PhysicianInpatient HIV ServiceGeneral Infectious Diseases Consult ServicesJohns Hopkins HospitalBaltimore, MarylandContent based on a CME program supported by educational grants from Gilead Sciences, Inc.; Theratechnologies; and ViiV Healthcare.Link to full program:https://bit.ly/33RZ9Zy Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In episode 3 of an ongoing series of sharing sessions between a physician and patient, Jordan J. Feld, MD, MPH, and Wendy, who is living with chronic hepatitis B, discuss the challenges of determining the best time to start treatment. The conversation focuses on incorporating shared decision-making, particularly for cases that are not straight forward and do not fit into an one specific category outlined by the guidelines. Presenter:Jordan J. Feld, MD, MPHAssociate Professor of MedicineUniversity of TorontoHepatologistToronto Centre for Liver DiseaseSandra Rotman Centre for Global HealthToronto, CanadaContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3u196yK Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, William R. Short, MD, MPH, AAHIVS, discusses current guidelines and clinical trial data informing optimal selection of first-line antiretroviral therapy for HIV.William R. Short, MD, MPH, AAHIVSAssociate Professor of MedicineDivision of Infectious DiseasesDepartment of Medicine Perelman School of Medicine at the University of PennsylvaniaPhiladelphia, PennsylvaniaContent based on a CME program supported by an independent educational grant from ViiV Healthcare.Link to full program:https://bit.ly/3ux6FF8 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In Part 4 of this 4-part series, listen to Howard Grossman, MD, and Cristina Mussini, MD, answer healthcare professionals’ questions on vaccine recommendations, bone health and fragility fractures, and racial disparities and social determinants that affect caring for patients aging with HIV.Presenters:Howard Grossman, MDClinical Affiliate Assistant ProfessorDepartment of Integrated Medical ScienceCharles E. Schmidt College of MedicineFlorida Atlantic UniversityBoca Raton, FloridaMedical Director, West Palm Beach, Wilton Manors, and Key WestMidway Specialty CareWilton Manors, FloridaCristina Mussini, MDHead, Department of Infectious Diseases and Tropical MedicineFull Professor of Infectious DiseaseInfectious Disease Clinics, University HospitalUniversity of Modena and Reggio EmiliaModena, Italy Content based on an online CME/CE/CPE-certified program supported by educational grants from Gilead Sciences, Inc.; Merck Sharp & Dohme Corp.; and ViiV Healthcare. Link to full program:http://bit.ly/32JD145 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Drs José R. Arribas, Andrew Carr, and Lynora Saxinger discuss simplification strategies for a virologically suppressed patient with HIV and a complex ART treatment history.Presenters:José R. Arribas, MDResearch Director, HIV and Infectious DiseasesHospital La Paz IdiPAZMadrid, SpainAndrew Carr, MBBS, MD, FRACP, FRCPAProfessor of MedicineUniversity of New South WalesDirector, HIV and Immunology UnitSt Vincent’s HospitalSydney, AustraliaLynora Saxinger, MD, FRCPC, CTropMedCochair, Scientific Advisory GroupAlberta COVID-19 EmergencyCoordination CentreAssociate ProfessorDivision of Infectious DiseasesDepartment of MedicineUniversity of AlbertaEdmonton, AlbertaCanadaContent based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc.Link to full program:https://bit.ly/3xdgcTk Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Drs José R. Arribas, Andrew Carr, and Lynora Saxinger discuss ART safety and management in a woman who wishes to conceive.Presenters:José R. Arribas, MDResearch Director, HIV and Infectious DiseasesHospital La Paz IdiPAZMadrid, SpainAndrew Carr, MBBS, MD, FRACP, FRCPAProfessor of MedicineUniversity of New South WalesDirector, HIV and Immunology UnitSt Vincent’s HospitalSydney, AustraliaLynora Saxinger, MD, FRCPC, CTropMedCochair, Scientific Advisory GroupAlberta COVID-19 EmergencyCoordination CentreAssociate ProfessorDivision of Infectious DiseasesDepartment of MedicineUniversity of AlbertaEdmonton, AlbertaCanadaContent based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc.Link to full program:https://bit.ly/3xdgcTk Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Drs José R. Arribas, Andrew Carr, and Lynora Saxinger discuss weight gain concerns for a patient with initiating ART.Presenters:José R. Arribas, MDResearch Director, HIV and Infectious DiseasesHospital La Paz IdiPAZMadrid, SpainAndrew Carr, MBBS, MD, FRACP, FRCPAProfessor of MedicineUniversity of New South WalesDirector, HIV and Immunology UnitSt Vincent’s HospitalSydney, AustraliaLynora Saxinger, MD, FRCPC, CTropMedCochair, Scientific Advisory GroupAlberta COVID-19 EmergencyCoordination CentreAssociate ProfessorDivision of Infectious DiseasesDepartment of MedicineUniversity of AlbertaEdmonton, AlbertaCanadaContent based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc.Link to full program:https://bit.ly/3xdgcTk Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In episode 2 of an ongoing series of sharing sessions between a physician and patient, Robert Gish, MD, FAASLD, and patient advocate, Alan Wang, discuss stigma as a barrier to optimal HBV care and treatment. The conversation focuses on how stigma affected Alan’s engagement with his care and strategies to overcome stigma as a barrier to HBV care.Presenter:Robert Gish, MD, FAASLD Medical DirectorHepatitis B FoundationMedical DirectorAsian Pacific Health Foundation San Diego, CaliforniaContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3u196yK Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In episode 1 of this ongoing series, listen to a conversation between Grace LH Wong, MD, and her patient, Ms. Chan, on the shared decision for Ms. Chan to start treatment for hepatitis B infection during her pregnancy.Presenter:Grace LH Wong, MDProfessorDivision of Gastroenterology and HepatologyDepartment of Medicine and TherapeuticsThe Chinese University of Hong KongHonorary ConsultantDivision of Gastroenterology and HepatologyDepartment of Medicine and TherapeuticsPrince of Wales HospitalHong KongContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3u196yK Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Chloe Orkin, MBChB, FRCP, MD, discusses exciting new HIV data reported at the virtual CROI 2021, including new findings on HIV PrEP, HIV and COVID-19, ART in pregnancy and the postpartum period, as well as on the comparative efficacy of various ARV regimens.Presenter:Chloe Orkin, MBChB, FRCP, MDProfessor of HIV Queen Mary University of LondonConsultant Physician Lead for HIV Research Barts Health NHS TrustThe Royal London HospitalLondon, United KingdomContent based on a CME program supported by educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.Link to full program:http://bit.ly/3eUPAj9 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In episode 17 of this series, Arthur Kim, MD, provides a brief update on the latest COVID-19 treatment options and guidelines. After the update, Dr. Kim answers questions submitted by healthcare professionals on various aspects of COVID-19. Presenter:Arthur Kim, MDAssociate ProfessorDepartment of MedicineHarvard Medical SchoolDirector, Viral Hepatitis ClinicDivision of Infectious DiseasesMassachusetts General HospitalBoston, Massachusetts Content based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3eDoJF0 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Dr. Bekker discusses results from key studies reported at the 4th HIV Research for Prevention Conference (HIVR4P // Virtual), including results from studies evaluating novel approaches to HIV prevention such as broadly neutralizing antibodies, long-acting injectable and oral ARVs, and implantable options. In addition, Dr. Bekker will discuss several studies evaluating different aspects of PrEP implementation and acceptance as well as considerations for multipurpose prevention strategies. Presenter:Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD DirectorDesmond Tutu HIV CentrePast PresidentInternational AIDS SocietyFaculty of Health SciencesUniversity of Cape TownCape Town, South AfricaContent based on a CME program supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.Link to full program:http://bit.ly/3s41GtM Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Dr. Jens Lundgren discusses results from key studies reported at the IAS COVID-19 Conference: Prevention, including new findings on potential SARS-CoV-2 suppressive therapies, strategies for vaccination and mass testing, and interventions to prevent transmission of COVID-19 while maintaining desired outcomes in HIV care.Jens D. Lundgren, MD, DMScProfessorRigshospitalet, University of CopenhagenCopenhagen, DenmarkDirectorCentre of Excellence for Health, Immunity and Infection (CHIP)Rigshospitalet, University of CopenhagenCopenhagen, Denmark Content based on a CME program supported by an independent educational grant from Gilead Sciences, Inc.Link to full program:http://bit.ly/3avWfhs Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Part 16 of an ongoing series, Sharon R. Lewin, AO, FRACP, PhD, FAHMS, provides a brief update on emerging COVID-19 variants and their potential impacts on vaccine efficacy. After the update, Professor Lewin answers questions submitted by healthcare professionals on various aspects of COVID-19. Presenter:Sharon R. Lewin, AO, FRACP, PhD, FAHMSDirector, The Peter Doherty Institute for Infection and ImmunityMelbourne Laureate Professor of Infectious Diseases University of MelbourneConsultant Infectious Diseases PhysicianAlfred Hospital and Royal Melbourne HospitalMelbourne, AustraliaContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3eDoJF0 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Part 3 of a 4-part series, Dr. Monica Gandhi, Dr. Rajesh Gandhi, and Dr. Josep Llibre discuss key health challenges faced by aging patients with HIV and answer clinicians’ questions on HIV treatment considerations and on prevention, screening, and treatment of common age-related comorbidities.Presenters:Monica Gandhi, MD, MPHProfessor of MedicineDivision of HIV, Infectious Diseases, and Global MedicineUniversity of California, San FranciscoMedical DirectorWard 86 HIV ClinicSan Francisco General HospitalSan Francisco, CaliforniaRajesh T. Gandhi, MDProfessor of MedicineDepartment of Infectious DiseasesHarvard Medical SchoolPhysician, Infectious DiseasesMassachusetts General HospitalBoston, MassachusettsJosep M. Llibre, MD, PhDSenior Consultant Physician and Clinical ResearcherDepartment of Infectious DiseasesLluita Contra La SIDA FoundationUniversity Hospital, Germans Trias i PujolBadalonaBarcelona, SpainContent based on an online CME/CE/CPE-certified program supported by educational grants from Gilead Sciences, Inc., Merck Sharp & Dohme Corp., and ViiV Healthcare.Link to full program:http://bit.ly/32JD145 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Part 15 of an ongoing series, Roger Paredes, MD, PhD, provides a brief update on emerging COVID-19 variants and their potential impacts on the pandemic. After the update, Dr. Paredes answers clinician questions on various aspects of COVID-19. Presenter:Roger Paredes, MD, PhDSection Chief, Infectious Diseases DepartmentGermans Trias i Pujol University Hospital Head of the Microbial Genomics Group IrsiCaixa AIDS Research InstituteBadalona, Catalonia, SpainContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3eDoJF0 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Part 14 of an ongoing series, Vikramjit Mukherjee, MD, provides a brief update on COVID-19 mortality trends, including the latest data on overall and in-hospital fatality rates. After the update, Dr. Mukherjee answers clinician questions on various aspects of COVID-19. Presenter:Vikramjit Mukherjee, MDAssistant Professor of MedicineDivision of Pulmonary, Critical Care, and Sleep MedicineNew York University School of MedicineDirector, Medical Intensive Care UnitBellevue HospitalNew York, New YorkContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:http://bit.ly/3eDoJF0 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Joseph J. Eron, Jr., MD; and Daniel R. Kuritzkes, MD; discuss evolving issues in first-line antiretroviral therapy, including 2-drug therapy, weight gain, and safety during conception and pregnancy.Presenters:Joseph J. Eron, Jr., MDProfessor of Medicine and EpidemiologyUniversity of North Carolina School of MedicineDirector, AIDS Clinical Trials UnitUniversity of North CarolinaChapel Hill, North CarolinaDaniel R. Kuritzkes, MDChief, Division of Infectious DiseasesBrigham and Women’s HospitalHarriet Ryan Albee Professor of MedicineHarvard Medical SchoolBoston, MassachusettsContent based on an online CME program supported by an independent educational grant from ViiV Healthcare.Link to full program:http://bit.ly/34fVILZ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, the third in a 3-part series on Ending the HIV Epidemic, Judith Feinberg, MD, and Kenneth Mayer, MD, discuss the important role of HIV pre-expsoure prophylaxis (PrEP) for preventing HIV infection among at-risk individuals and critical strategies for effective PrEP implementation among principle populations, including men who have sex with men and transgender women, heterosexual cisgender women, and people who inject drugs. Following their dialogue, the faculty field clinician questions on HIV prevention.Presenters:Judith Feinberg, MDProfessorAttending PhysicianDepartments of Medicine and Behavioral Medicine & PsychiatryWest Virginia University School of MedicineMorgantown, West VirginiaKenneth Mayer, MDInfectious Disease AttendingBeth Israel Deaconess Medical CenterProfessor of MedicineHarvard Medical SchoolMedical Research DirectorFenway Community HealthBoston, MassachusettsContent based on an online CME program supported by educational grants from Gilead Sciences and ViiV Healthcare and produced in collaboration with PCE and HealthHIV.Link to full program:http://bit.ly/3263Q1s Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Roger Bedimo, MD, MS, FACP, and Eric S. Daar, MD, discuss caring for heavily treatment–experienced patients with HIV, including assessment of virologic failure and current treatment options for patients with multiclass drug resistance.Presenters:Roger Bedimo, MD, MS, FACP Professor of MedicineDivision of Infectious Diseases University of Texas Southwestern Medical Center Section ChiefDivision of Infectious Diseases Department of Internal Medicine VA North Texas Health Care System Dallas, TexasEric S. Daar, MDChiefDivision of HIV Medicine Harbor-UCLA Medical Center Professor of MedicineDavid Geffen School of Medicine at UCLA Los Angeles, CaliforniaContent based on an online CME program supported by an independent educational grant from ViiV Healthcare.Link to full program:http://bit.ly/34fVILZ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Part 13 of an ongoing series, Jens D. Lundgren, MD, DMSc, provides a brief update monoclonal antibody treatments for COVID-19, including the FDA Emergency Use Authorization for bamlanivimab and discusses the recently released information on COVID-19 vaccine efficacy. After the update, Professor Lundgren answers clinician questions on various aspects of COVID-19. Presenter:Jens D. Lundgren, MD, DMScProfessorRigshospitalet, University of CopenhagenCopenhagen, DenmarkDirectorCentre of Excellence for Health, Immunity and Infection (CHIP)Rigshospitalet, University of CopenhagenCopenhagen, DenmarkContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3eDoJF0 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, the second in a 3-part series on Ending the HIV Epidemic, Jason Halperin, MD, MPH, and Aadia I. Rana, MD, discuss treatment as prevention, the critical infrastructure needed to implement rapid ART, the importance of routinely assessing for barriers to care, and real-time monitoring strategies that improve patient adherence and engagement. Following their dialogue, the faculty field clinician questions on HIV treatment and retention in care.Presenters:Jason Halperin, MD, MPHAssistant Professor of MedicineDepartment of Infectious DiseasesTulane UniversityInfectious Disease PhysicianCrescentCareNew Orleans, LouisianaAadia I. Rana, MDAssociate Professor of MedicineDivision of Infectious Diseases The University of Alabama at Birmingham 1917 ClinicBirmingham, AlabamaContent based on an online CME program supported by educational grants from Gilead Sciences and ViiV Healthcare and produced in collaboration with PCE and HealthHIV.Link to full program:https://bit.ly/3263Q1s Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Dr. Terrault discusses results from key viral hepatitis studies reported at the American Association for the Study of LiverDiseases (AASLD) 2020 annual conference, The Liver Meeting Digital Experience, including new findings on HBV treatment and management, hepatocellular carcinoma risk, and emerging approaches to HCV care in underserved populations.Presenter:Norah Terrault, MD, MPHProfessor of MedicineChief of Gastrointestinal and Liver DiseasesUniversity of Southern CaliforniaLos Angeles, CaliforniaContent based on a CME program supported by an independent educational grant from Gilead Sciences, Inc.Link to full program: https://bit.ly/37bBrce Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Brian Wood, MD, discusses HIV treatment safety and tolerability data from 2020 conferences and addresses how he manages ARV-associated weight gain his patients and how the latest data on ART safety during conception and pregnancy impact his treatment recommendations.Presenters:Brian Wood, MDAssociate Professor of MedicineDivision of Allergy and Infectious DiseasesUniversity of WashingtonSeattle, WashingtonContent based on an online CME/CE/CPE-certified program supported by educational grants from Janssen Therapeutics, Division of Janssen Products, LP.Link to full program:https://bit.ly/38YZVrz Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Part 2 of an 4-part series, Dr. Jonathan Appelbaum, Dr. Howard Grossman, and Professor Jürgen Rockstroh discuss key health challenges faced by aging patients with HIV and answer clinicians’ questions on HIV treatment considerations and on prevention, screening, and treatment of common age-related comorbidities.Presenters:Jonathan Appelbaum MD, FACP, AAHIVSLaurie L. Dozier Jr, MD, Education DirectorProfessor of MedicineChair, Department of Clinical SciencesFlorida State University College of MedicineTallahassee, FloridaHoward Grossman, MDClinical Affiliate Assistant ProfessorDepartment of Integrated Medical ScienceCharles E. Schmidt College of MedicineFlorida Atlantic UniversityBoca Raton, FloridaMedical Director, West Palm Beach, Wilton Manors, and Key WestMidway Specialty CareWilton Manors, FloridaJürgen Rockstroh, MDProfessor of MedicineUniversity of BonnBonn, GermanyContent based on an online CME/CE/CPE-certified program supported by educational grants from Gilead Sciences, Inc., Merck Sharp & Dohme Corp., and ViiV Healthcare.Link to full program:https://bit.ly/32JD145 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Dr. Joseph Eron and Dr. Jason Halperin discuss caring for complex HIV cases, including patients with underlying resistance or comorbidities.Presenters:Joseph J. Eron, Jr., MDProfessor of Medicine and EpidemiologyUniversity of North Carolina School of MedicineDirector, AIDS Clinical Trials UnitUniversity of North CarolinaChapel Hill, North CarolinaJason Halperin, MD, MPHAssistant Professor of MedicineDepartment of Infectious DiseasesTulane UniversityInfectious Disease PhysicianCrescentCareNew Orleans, LouisianaContent based on an online CME program supported by an independent educational grant from ViiV Healthcare.Link to full program:https://bit.ly/34fVILZ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Part 12 of an ongoing series, David Heymann, BA, MD, DTM&H, provides a brief update on strategies for moving forward and living safely within the continued COVID-19 pandemic. After the update, Professor Heymann answers clinician questions on various aspects of COVID-19. Presenter:David Heymann, BA, MD, DTM&H Professor of Infectious Disease EpidemiologyLondon School of Hygiene & Tropical MedicineLondon, EnglandContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3eDoJF0 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, the first in a 3-part series on Ending the HIV Epidemic, Lisa K. Fitzpatrick, MD, MPH, MPA, and David Malebranche, MD, MPH, discuss strategies to expand early HIV testing, maximize patient engagement in HIV care, navigate emerging clusters of HIV infection, and combat HIV-related stigma. Following their dialogue, the faculty field clinician questions on HIV diagnosis and management. Presenters:Lisa K. Fitzpatrick, MD, MPH, MPAProfessorial LecturerDepartment of EpidemiologyGeorge Washington University School of Public HealthInterim Medical DirectorBlueRock CareWashington, DCDavid J. Malebranche, MD, MPHBoard-Certified Internal Medicine PhysicianHIV SpecialistContent based on an online CME program supported by educational grants from Gilead Sciences and ViiV Healthcare and produced in collaboration with PCE and HealthHIV.Link to full program:https://bit.ly/3263Q1s Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Dr. Gandhi discusses results from key studies reported at the virtual IDWeek 2020 conference, including new findings on transmission in different settings, symptom progression and clinical outcomes, detection of non-SARS-CoV-2 viruses during the pandemic, and treatment and prevention strategies.Presenter:Rajesh T. Gandhi, MD Professor of Medicine Department of Infectious DiseasesHarvard Medical SchoolPhysician, Infectious DiseasesMassachusetts General HospitalBoston, MassachusettsContent based on a CME program supported by an independent educational grant from Gilead Sciences, Inc.Link to full program:https://bit.ly/35HxQS8 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Part 11 of an ongoing series, Sharon R. Lewin AO, FRACP, PhD, FAHMS, provides a brief update on the role of interferons in COVID-19. After the update, Dr. Lewin answers clinician questions on various aspects of COVID-19. Presenter:Sharon R. Lewin AO, FRACP, PhD, FAHMSDirector, The Peter Doherty Institute for Infection and ImmunityMelbourne Laureate Professor of Infectious Diseases University of MelbourneConsultant Infectious Diseases PhysicianAlfred Hospital and Royal Melbourne HospitalContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3eDoJF0 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Dr. Sherer discusses results from key studies reported at the 2020 International Congress on Drug Therapy in HIV Infection (HIV Glasgow 2020 Virtual), including studies on long-term 2-drug and 3-drug antiretroviral therapy, newer 3-drug regimens in patients with baseline NRTI resistance, investigational HIV treatment approaches, and important comoribidities in patients with HIV, including COVID-19.Presenter:Renslow Sherer, MDDirector, International HIV Training CenterProfessor of MedicineUniversity of ChicagoChicago, IllinoisContent based on a CME program supported by independent educational grants from Gilead Sciences, Inc., Janssen Therapeutics, Division of Janssen Products, LP, and ViiV Healthcare.Link to full program:https://bit.ly/35nGqph Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Part 10 of an ongoing series, Wong Chen Seong, MBBS, MRCP(UK), FAMS, provides a brief update on COVID-19 and HIV. After the update, Dr. Wong answers clinician questions on various aspects of COVID-19.Presenter:Wong Chen Seong, MBBS, MRCP(UK), FAMSHead, NCID Clinical HIV ProgrammeDeputy Director, National HIV ProgrammeNational Centre for Infectious Diseases ConsultantDepartment of Infectious DiseasesTan Tock Seng Hospital Programme DirectorNHG Infectious Diseases Residency ProgrammeAdjunct Assistant ProfessorYong Loo Lin School of MedicineNational University of SingaporeSingaporeContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3eDoJF0 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Dr. Rath discusses results from key studies reported at the European Society of Clinical Microbiology and Infectious Diseases Conference on Corona Virus Disease (ECCVID), including studies on COVID-19 screening and diagnostics, vaccines, prevention strategies, social disparities, and therapeutics.Presenter:Barbara Rath, MD, PhD, HDR Co-founder & Chair The Vienna Vaccine Safety InitiativeResearch DirectorUniversité de Bourgogne Franche-Comté, FranceHonorary ProfessorExecutive Board MemberESGREV (Respiratory Virus Study Group for ESCMID) Content based on CME program supported by an independent educational grant from Merck & Co., Inc.Link to full program:https://bit.ly/37e6Hcc Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Part 9 of an ongoing series, Lynora Saxinger, MD, FRCPC, CTropMed, provides a brief update on key concepts in COVID-19 immunity and the latest information on treatment strategies. After the update, Dr. Saxinger answers clinician questions on various aspects of COVID-19. Presenter:Lynora Saxinger, MD, FRCPC, CTropMedCochair, Scientific Advisory GroupAlberta COVID-19 Emergency Coordination CentreAssociate ProfessorDepartment of MedicineDivision of Infectious DiseasesUniversity of AlbertaEdmonton, AlbertCanadaContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3eDoJF0 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Part 8 of an ongoing series, Paul E. Sax, MD, provides a brief update on current treatment options for COVID-19. After the update, Dr. Sax answers clinician questions on various aspects of COVID-19.Presenter:Paul E. Sax, MDClinical Director HIV Program and Division of Infectious DiseasesBrigham and Women's HospitalProfessor of MedicineHarvard Medical SchoolBoston, MassachusettsContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3eDoJF0 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, W. David Hardy, MD, discusses current guidelines and clinical trial data informing optimal selection of first-line antiretroviral therapy for HIV.Presenter:W. David Hardy, MDScientific and Medical ConsultantAdjunct Professor of MedicineDivision of Infectious Diseases Johns Hopkins University School of MedicineBaltimore, MarylandContent based on an online CME program supported by an independent educational grant from ViiV Healthcare.Link to full program:https://bit.ly/34fVILZ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Part 7 of an ongoing 12-part COVID-19 series, Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS, provides a brief update on COVID-19 risk and prevention strategies among healthcare workers. After the update, Professor Leo answers clinician questions on various aspects of COVID-19. Presenter:Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMSProfessorLee Kong Chian School of MedicineSaw Swee Hock School of Public HealthNanyang Technological UniversityNational University of SingaporeSenior ConsultantNational Centre for Infectious DiseaseSingaporeContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3eDoJF0 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Part 6 of an ongoing 12-part COVID-19 series, Jens D. Lundgren, MD, DMSc, provides a brief update on vaccine development and treatment strategies. After the update, Dr. Lundgren answers clinician questions on various aspects of COVID-19. Note that this podcast was recorded on August 4, 2020. Some information may have changed since that time.Presenter:Jens D. Lundgren, MD, DMScProfessorRigshospitalet, University of CopenhagenCopenhagen, DenmarkDirectorCentre of Excellence for Health, Immunity and Infection (CHIP)Rigshospitalet, University of CopenhagenCopenhagen, DenmarkContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3eDoJF0 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Part 1 of an 4-part series, Dr. Joseph J. Eron, Jr., Professor Chloe Orkin, and Dr. Paul E. Sax, discuss key health challenges faced by aging patients with HIV and answer clinicians’ questions on HIV treatment considerations and on prevention, screening, and treatment of common age-related comorbidities.Presenters:Joseph J. Eron, Jr., MDProfessor of Medicine and EpidemiologyUniversity of North Carolina School of MedicineDirector, AIDS Clinical Trials UnitUniversity of North CarolinaChapel Hill, North Carolina Chloe Orkin, MBChB, FRCP, MDProfessor of HIVQueen Mary, University of LondonConsultant PhysicianLead for HIV ResearchBarts Health NHS TrustThe Royal London HospitalLondon, United KingdomPaul E. Sax, MDClinical Director HIV Program and Division of Infectious DiseasesBrigham and Women’s HospitalProfessor of MedicineHarvard Medical SchoolBoston, MassachusettsContent based on an online CME/CE/CPE-certified program supported by educational grants from Gilead Sciences, Inc., Merck Sharp & Dohme Corp., and ViiV Healthcare.Link to full program:https://bit.ly/32JD145 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Dr. Stefan Zeuzem discusses results from key viral hepatitis studies reported at the 2020 Digital International Liver Congress, organized by the European Association for the Study of the Liver, including important findings from the following reports:Update on global progress toward HCV elimination goalsSToP-C: HCV treatment-as-prevention in Australian prisonsSHARED cohort: correlates of treatment failure with GLE/PIB or SOF/VEL/VOXTrio Health: retreating HCV with GLE/PIB or SOF/VEL/VOX after DAA failureStop-NUC: discontinuation of long-term nucleos(t)ide analogue therapy in patients with HBeAg-negative chronic HBV infectionHigh-dose bulevirtide for chronic HBV/HDV coinfectionSummary of select agents under early-phase investigation for HBV treatmentPresenter:Stefan Zeuzem, MDProfessor of Medicine Chief, Department of Medicine I JW Goethe University Hospital Frankfurt, GermanyContent based on a CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/33nkRUI Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Part 5 of an ongoing 12-part COVID-19 series, David Heymann, BA, MD, DTM&H, provides a brief update on the epidemiology of SARS-CoV-2 and evidence-based interventions for reducing transmission,. After the update, Professor Heymann answers critical clinician questions on COVID-19 transmission and mitigation.Presenter:David Heymann, BA, MD, DTM&HProfessor, Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine; andDistinguished Fellow, Centre on Universal Health at Chatham House, LondonLondon, United KingdomContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program: https://bit.ly/3eDoJF0 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Dr. Sherer discusses results from key studies reported at the International AIDS Society’s 2020 Virtual COVID-19 Conference, including studies evaluating characteristics and predictors of COVID-19 mortality, factors associated with remdesivir clinical outcomes, the effect of hydroxychloroquine coadministration on remdesivir safety and efficacy, the effect of race/ethnicity on clinical outcomes with remdesivir, and sofosbuvir/daclatasvir plus lopinavir/ritonavir for the treatment of severe COVID-19.Presenter:Renslow Sherer, MDDirector, International HIV Training CenterProfessor of MedicineUniversity of ChicagoChicago, IllinoisContent based on a CME program supported by an independent educational grant from Gilead Sciences.Link to full program: https://bit.ly/2Q7GDp2 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Dr. Orkin discusses results from key studies reported at AIDS 2020: Virtual, with new data on the following hot topics: current ART in principal populations, including older patients and women who become pregnant; metabolic outcomes during ART; HIV and COVID-19; investigational ART strategies; and HIV prevention. The overview includes: The ADVANCE trial comparing initial ART with DTG plus FTC/TAF, DTG plus FTC/TDF, or EFV/FTC/TDFA pooled analysis of randomized trials evaluating a switch to BIC/FTC/TAF in patients 65 years of age or older with virologic suppression on their current ARTA Kaiser Permanente study of BMI changes over time following ART initiation An analysis of the longitudinal prospective OPERA cohort that assessed weight change with switch from TDF to TAFMetabolic changes with switch from 3- or 4-drug TAF-based ART to 2-drug DTG/3TC in the TANGO studyUpdated findings from the Tsepamo birth surveillance study in Botswana evaluating the prevalence of neural tube defects by antiretroviral exposure during conception/pregnancyA retrospective study of COVID-19 in people with HIV presenting at 5 New York City Emergency Departments from March 2 to April 15, 2020An analysis of protocol-defined virologic failure in the P011 study comparing islatravir plus DOR vs DOR/3TC/TDF in treatment-naive adultsA study evaluating the lenacapavir pharmacokinetic profileResults from the HPTN 083 trial investigating the efficacy and safety of long-acting injectable cabotegravir vs daily oral TDF/FTC for PrEP in MSM and TGWPresenter:Chloe Orkin, MBChB, FRCP, MDProfessor of HIV Queen Mary, University of LondonConsultant PhysicianLead for HIV Research Barts Health NHS TrustThe Royal London HospitalLondon, United KingdomContent based on a CME program supported by independent educational grants from Gilead Sciences, Merck Sharp & Dohme Corp., and ViiV Healthcare.Link to full program: https://bit.ly/33YRz0t Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Part 4 of an ongoing 12-part COVID-19 series, Vikramjit Mukherjee, MD, provides a brief update on the latest incidence trends and a concise summary of updates to the US National Institutes of Health and the Infectious Diseases Society of America recommendations for managing COVID-19. After the update, Dr. Mukherjee answers critical clinician questions on COVID-19 transmission, diagnosis, and management.Presenter:Vikramjit Mukherjee, MDDirector, Medical Intensive Care UnitBellevue HospitalAssistant ProfessorDivision of Pulmonary, Critical Care, and Sleep MedicineNYU School of MedicineNew York, New YorkContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3eDoJF0 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Christian B. Ramers, MD, MPH, and Sandra Springer, MD, discuss current evidence supporting the need for integrated addiction and infectious disease care and review the wide array of benefits that can be realized when these services are provided in tandem, ideally at the same clinic and by the same healthcare provider.Presenters:Christian B. Ramers, MD, MPHAssociate Clinical ProfessorDivision of Infectious DiseasesDepartment of MedicineUC San Diego School of MedicineLa Jolla, CaliforniaChief, Population HealthDirector, Graduate Medical EducationFamily Health Centers of San DiegoSan Diego, CaliforniaSandra Springer, MD Associate Professor of MedicineDivision of Infectious DiseaseDepartment of Internal MedicineYale School of MedicineNew Haven, ConnecticutAttending PhysicianSection of Infectious DiseaseDepartment of Internal MedicineVeterans Administration Connecticut Healthcare ServicesWest Haven, ConnecticutContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/2Zcdoqw Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Part 3 of an ongoing 12-part COVID-19 series, Sharon Lewin, AO, FRACP, PhD, FAAHMS, provides a brief update on the latest incidence trends and a concise guide to the management of mild and moderate disease. After the update, Dr. Lewin answers critical clinician questions on COVID-19 transmission, diagnosis, and management.Presenter:Sharon Lewin, AO, FRACP, PhD, FAAHMSDirectorThe Peter Doherty Institute for Infection and ImmunityProfessor of Infectious DiseasesUniversity of MelbourneConsultant Infectious Disease PhysicianAlfred Hospital and Royal Melbourne HospitalMelbourne, AustraliaContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program: https://bit.ly/3eDoJF0 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Part 2 of an ongoing 12-part COVID-19 series, Jens D. Lundgren, MD, DMSc, provides a brief update on the latest incidence trends, a concise guide to viral diagnostic testing, and new data on investigational treatment options. After the update, Dr. Lundgren answers critical clinician questions on COVID-19 transmission, diagnosis, and management.Presenter:Jens D. Lundgren, MD, DMScProfessorDirector, Centre of Excellence for Health, Immunity and Infection (CHIP)RigshospitalUniversity of CopenhagenCopenhagen, DenmarkContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program: https://bit.ly/3eDoJF0 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Dr. Gandhi discusses topline results from several studies investigating weight gain and metabolic outcomes with different antiretroviral therapy (ART) regimens among patients with HIV, including lipid level changes, cardiovascular disease risk, diabetes risk, and metabolic syndrome risk. The overview will include analyses from: The ADVANCE trial comparing initial ART with DTG plus FTC/TAF, DTG plus FTC/TDF, or EFV/FTC/TDF, including an examination of the influence of CYP2B6 polymorphisms on weight change during EFV-based therapyThe NA-ACCORD studyEvaluating patients with virologic suppression who switched from non–integrase inhibitor (INSTI)–based regimens to INSTI-based regimensInvestigating the impact of initial ART regimen class on diabetes mellitus incidenceA study investigating the association between resting metabolic rate, oxygen consumption, and dietary intake changes and body weight/composition changes following ART initiationA study evaluating differences in postpartum weight change with DTG-based vs EFV-based ARTIn addition, Dr. Gandhi reviews new information on biomedical prevention of HIV infection, including results from several preclinical trials, a study investigating real-time urine-based testing for tenofovir levels, and the latest safety data from the phase III DISCOVER trial comparing FTC/TDF vs FTC/TAF for daily oral HIV pre-exposure prophylaxis (PrEP) among cis-gender men who have sex with men (MSM) and transgender women.Presenter:Monica Gandhi, MD, MPH Professor of MedicineDivision of HIV, Infectious Diseases, and Global MedicineUniversity of California, San FranciscoMedical DirectorWard 86 HIV ClinicSan Francisco General HospitalSan Francisco, CaliforniaContent based on an online CME program supported by independent educational grants from Gilead Sciences; Merck & Co., Inc.; and ViiV Healthcare.Link to full program: https://bit.ly/3bBjeoD Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Part 1 of an ongoing 12-part COVID-19 series, Vikramjit Mukherjee, MD, provides a brief update on the latest incidence trends, the role of serology in disease assessment, and newly published data from the ACTT-1 trial comparing remdesivir vs placebo for severe COVID-19 treatment. After the update, Dr. Mukherjee answers critical clinician questions on COVID-19 transmission, diagnosis, and management.Presenter:Vikramjit Mukherjee, MDDirector, Medical Intensive Care UnitBellevue HospitalAssistant ProfessorDivision of Pulmonary, Critical Care, and Sleep MedicineNYU School of MedicineNew York, New YorkContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program: https://bit.ly/3eDoJF0 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.